Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide LAR in Later-Stage ADPKD
NCT01377246Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- May 2011
- Primary completion
- Oct 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of octreotide in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Mario Negri Institute for Pharmacological Research. Started May 2011; status: completed.
02
Drugs
octreotide
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT01377246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01377246.